Navigating COVID with Migraine in Europe
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- How has the pandemic affected people with migraine in Europe?
- What are some changes resulting from the pandemic that actually could benefit people with migraine?
- How did patients and physicians handle procedures that must be done in-office, like injections or infusions?
- Are telehealth options going to remain available, even as things open back up?
- Can the COVID vaccine trigger a migraine attack in some people?
- What is the mechanism that triggers a migraine attack from either the vaccine or COVID itself?
- Should people with migraine stop taking their migraine medication when receiving the vaccination or during the course of the disease if they get COVID?
- When did researchers start noticing a prevalence of headache associated with COVID?
- What type of headache can be expected for a person with migraine who gets COVID?
- Are migraine medications effective for COVID headaches?
- At what point does headache typically appear in the COVID disease process?
- Is the use of steroids recommended for treatment of headache during COVID?
- Can COVID lead to migraine in someone who didn’t have it prior to getting the virus?
- How common are prolonged headache symptoms in people with migraine after having COVID?
- Are people with migraine more likely to develop prolonged headache symptoms after COVID than someone without migraine?
- What is the best treatment for someone who has developed chronic migraine from long COVID?
- Are there any medications a person with migraine from long COVID should avoid?
- Is taking medication preemptively to avoid side effects of the vaccine recommended?
- What does the research say about the severity of COVID in people with migraine?
- Is it possible that having migraine could actually be a protective factor with COVID?
- Are people with migraine more susceptible to COVID?
Interview Notes
Find more about Patricia Pozo Rosich, MD, PhD and her work here:
- Dr. Pozo-Rosich’s website
- Study on persistent headache after COVID
- Headache as a Symptom of Covid-19: Narrative Review of 1-year Research
- Safety of Anti-CGRP Monoclonal Antibodies in Patients With Migraine During the COVID-19 Pandemic
Treatments Mentioned
- Amitriptyline
- Analgesics (paracetamol)
- Beta blockers
- Botox
- CGRP antibodies
- NSAIDs
- Steroids
- Topiramate
Please note: The Migraine World Summit’s aim is to bring you a variety of perspectives and expertise, independent of bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.
Patricia Pozo-Rosich, MD, PhD
Head of Neurology Section
Vall d’Hebron Hospital and Institute of Research, Spain
As the director of headache and neurological pain research at Vall d’Hebron Institute of Research in Barcelona, Spain, Dr. Pozo-Rosich is one of the leading migraine researchers in Europe. An active leader in the field of international headache medicine, Dr. Pozo-Rosich is passionate about educating patients and clinicians about migraine. She is the coordinator of the Headache Study Group of the Spanish Neurological Society (GECSEN). Additionally, she is the founder of the Spanish-language website MiDolordeCabeza.org. In 2023, she was awarded the Cephalalgia Award for her article “Salivary CGRP Can Monitor the Different Migraine Phases: CGRP (In)dependent Attacks,” which she presented at the International Headache Congress in Seoul, Korea.
Dr. Pozo-Rosich is a member of the International Headache Society, the American Headache Society, the International Headache Genetics Consortium, and the Catalan Neurological Society.
Interviews from Patricia Pozo-Rosich, MD, PhD
European Headache Treatment Update
Navigating COVID with Migraine in Europe
How Pain Works in the Migraine Brain
How to Get the Most from Your Doctor
Solving the Puzzle of What’s Causing Migraines
Purchase full access to the entire 2024 Summit. Includes:
- All expert interviews with separate audio (MP3) files & transcripts
- Lifetime on-demand access with no annual fee to 2024 Summit
- Interview Summaries
- Treatment Guidelines
- And much more!
Related Talks for: Day 6 (2022)
Chronic Cluster Headache
Christopher Gottschalk, MD, FAHS
Learning How to Sleep Better with Migraine
Alex Dimitriu, MD
How We Got to Now: A History of Migraine
Katherine Foxhall, PhD
Miles for Migraine is a registered 501(c)(3) nonprofit organization with the mission of improving the lives of people with migraine and other headache disorders, and their families, by raising public awareness about this disease, and helping to find a cure. Miles for Migraine produces fun walk/run events, typically a 2-mile walk and 5K and 10K races to raise money for migraine research. We also host adult education days, and a youth program for kids and teens impacted by migraine and other headache disorders.
You can comment at the bottom of each interview page. Most pages have responses from the Migraine World Summit hosts and sometimes from the experts themselves!
